Agilent Technologies Inc (NYSE:A) Short Interest Update

Agilent Technologies Inc (NYSE:A) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 5,260,000 shares, a growth of 8.5% from the April 30th total of 4,850,000 shares. Based on an average daily trading volume, of 2,520,000 shares, the short-interest ratio is presently 2.1 days. Currently, 1.7% of the shares of the company are sold short.

Several research analysts have commented on A shares. Piper Sandler raised their price target on shares of Agilent Technologies from $86.00 to $96.00 and gave the company an “overweight” rating in a report on Wednesday, February 19th. Citigroup cut their price target on shares of Agilent Technologies from $85.00 to $75.00 and set a “neutral” rating for the company in a report on Friday, March 20th. Barclays cut their price target on shares of Agilent Technologies from $85.00 to $76.00 and set an “equal weight” rating for the company in a report on Thursday, March 26th. Zacks Investment Research raised shares of Agilent Technologies from a “sell” rating to a “hold” rating and set a $89.00 price target for the company in a report on Friday, February 21st. Finally, Wells Fargo & Co cut their price target on shares of Agilent Technologies from $100.00 to $82.00 and set an “overweight” rating for the company in a report on Monday, March 30th. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $80.43.

In related news, CEO Michael R. Mcmullen sold 13,603 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, April 29th. The shares were sold at an average price of $78.72, for a total value of $1,070,828.16. Following the completion of the transaction, the chief executive officer now directly owns 529,245 shares in the company, valued at approximately $41,662,166.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Mark Doak sold 3,494 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, March 3rd. The shares were sold at an average price of $83.81, for a total transaction of $292,832.14. Following the completion of the transaction, the vice president now owns 135,678 shares of the company’s stock, valued at $11,371,173.18. The disclosure for this sale can be found here. Insiders sold a total of 43,929 shares of company stock valued at $3,476,727 over the last quarter.

A number of institutional investors have recently bought and sold shares of the business. Column Capital Advisors LLC lifted its stake in Agilent Technologies by 26.0% in the first quarter. Column Capital Advisors LLC now owns 606 shares of the medical research company’s stock worth $43,000 after purchasing an additional 125 shares during the last quarter. Bowen Hanes & Co. Inc. increased its position in shares of Agilent Technologies by 4.1% in the fourth quarter. Bowen Hanes & Co. Inc. now owns 3,310 shares of the medical research company’s stock valued at $282,000 after acquiring an additional 130 shares during the period. Northwestern Mutual Wealth Management Co. increased its position in shares of Agilent Technologies by 6.1% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,484 shares of the medical research company’s stock valued at $178,000 after acquiring an additional 143 shares during the period. MainStreet Investment Advisors LLC increased its position in shares of Agilent Technologies by 4.3% in the fourth quarter. MainStreet Investment Advisors LLC now owns 3,543 shares of the medical research company’s stock valued at $302,000 after acquiring an additional 145 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. increased its position in shares of Agilent Technologies by 21.8% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 861 shares of the medical research company’s stock valued at $62,000 after acquiring an additional 154 shares during the period.

NYSE A opened at $80.75 on Friday. Agilent Technologies has a 52-week low of $61.13 and a 52-week high of $90.64. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.27 and a current ratio of 1.64. The company has a market capitalization of $25.30 billion, a P/E ratio of 33.37 and a beta of 1.10. The company has a fifty day moving average of $77.14 and a 200-day moving average of $79.93.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Thursday, May 21st. The medical research company reported $0.71 earnings per share for the quarter, topping the consensus estimate of $0.61 by $0.10. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.20 billion. Agilent Technologies had a net margin of 14.59% and a return on equity of 20.49%. The firm’s revenue for the quarter was up .2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.71 earnings per share. As a group, analysts forecast that Agilent Technologies will post 2.95 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st were paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.89%. The ex-dividend date was Monday, March 30th. Agilent Technologies’s dividend payout ratio is presently 23.15%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Further Reading: Consumer behavior in bull markets

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.